This article disusses management of hypertrophic cardiomyopathy and how contemporary treatments have effectively transformed HCM into a highly treatable condition with relatively low morbidity/mortality.
Editors
Editor-in-Chief Valentin Fuster, MD, PhD, MACC
CME EditorRagavendra R. Baliga, MD
Authors Barry J. Maron, MD
Important Dates
Date of Release: January 24, 2022Term of Approval/Date of CME/MOC/ECME Expiration: January 23, 2023